Beta Blockers and Breast Cancer Mortality: A Population- Based Study

Thomas I. Barron, Roisín M. Connolly, Linda Sharp, Kathleen Bennett, Kala Visvanathan

Journal of Clinical Oncology · 2011 · 510 citations · 24 references

Abstract

The results provide evidence in humans to support preclinical observations suggesting that inhibiting the β₂-adrenergic signaling pathway can reduce breast cancer progression and mortality.

References

24